Przemyslaw M. Bozko

Otfried Mueller Str. 10
Tuebingen, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Proteomic Analysis of TCGA Data Reveals Limited Prognostic Value of p53 but Suggests BAX as a Potential Survival Marker in Cervical Carcinoma.

Proteomic Analysis of TCGA Data Reveals Limited Prognostic Value of p53 but Suggests BAX as a Potential Survival Marker in Cervical Carcinoma.

Journal: International journal of molecular sciences
Published: May 20, 2026

PBMC‑secreted Sgp130FcH Inhibits Colorectal Cancer Cells and Cholangiocarcinoma: Proof‑of‑Concept Evidence.

PBMC‑secreted Sgp130FcH Inhibits Colorectal Cancer Cells and Cholangiocarcinoma: Proof‑of‑Concept Evidence.

Journal: Current cancer drug targets
Published: March 06, 2026

Adiponectin Receptor Agonist Suppresses Human Colorectal Cancer.

Adiponectin Receptor Agonist Suppresses Human Colorectal Cancer.

Journal: Anticancer research
Published: April 24, 2025

High p53 Protein Level Is a Negative Prognostic Marker for Pancreatic Adenocarcinoma.

High p53 Protein Level Is a Negative Prognostic Marker for Pancreatic Adenocarcinoma.

Journal: International journal of molecular sciences
Published: September 25, 2024

Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer Cells.

Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer Cells.

Journal: Anticancer research
Published: July 16, 2024

Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth.

Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth.

Journal: Cell biochemistry and biophysics
Published: October 30, 2023

Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase.

Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase.

Journal: Current medicinal chemistry
Published: March 25, 2023

The safety of CAR-T cells and PD-1 antibody combination on an experimental model.

The safety of CAR-T cells and PD-1 antibody combination on an experimental model.

Journal: Biochemical and biophysical research communications
Published: January 06, 2023

Determination of Both TP53 Mutation Status and the Amount of p53 Protein has Limited Diagnostic Importance for Patients with Ovarian Cancer.

Determination of Both TP53 Mutation Status and the Amount of p53 Protein has Limited Diagnostic Importance for Patients with Ovarian Cancer.

Journal: Current medicinal chemistry
Published: September 10, 2021

Cholangiocarcinoma Therapeutics: An Update.

Cholangiocarcinoma Therapeutics: An Update.

Journal: Current cancer drug targets
Published: September 01, 2020

Cell-to-Cell Transmission of the Unfolded Protein Response - Is it a Real Phenomenon?

Cell-to-Cell Transmission of the Unfolded Protein Response - Is it a Real Phenomenon?

Journal: Current medicinal chemistry
Published: July 20, 2020

Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma.

Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma.

Journal: Journal of gastroenterology and hepatology
Published: June 06, 2020
Showing 1-12 of 38

Last Updated: 09/26/2026